IFNG and diabetes mellitus: Recent studies suggest that Th17 cells exhibit flexibility of function and can modify their phenotype, including acquisition of IFN-γ production in response to IL-12 or IL-23 in vitro or during induction of diabetes and colitis (Bending et al., 2009; Lee et al., 2009).